REG - Kromek Group PLC - Result of AGM

KromekAnnouncement

26/09/2019 13:15

RNS Number : 8287N
Kromek Group PLC
26 September 2019
 


26 September 2019 
 
Kromek Group plc
("Kromek" or the "Group")
 
Result of AGM
 
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that at its Annual General Meeting ("AGM"), held earlier today, all resolutions were duly passed.
 
Details of the proxy voting results, which should be read alongside the Notice of AGM, are below:
 



Resolution


Votes for*


Votes against


Votes withheld


Total proxy votes








No. of votes


% of votes cast


No. of votes


% of votes cast


No. of votes








1


137,480,385


95.87


5,915,926


4.13


3,564


143,396,311




2


143,275,348


99.92


112,885


0.08


11,642


143,416,632




3


143,303,747


99.94


84,486


0.06


11,642


143,388,233




4


143,299,584


99.94


88,649


0.06


11,642


143,388,233




5


137,357,133


95.81


6,010,791


4.19


31,951


143,367,924




6


143,270,033


99.94


92,766


0.06


37,076


143,362,799




7


143,213,552


99.89


152,202


0.11


34,121


143,365,754




8


143,080,295


99.79


303,053


0.21


16,524


143,383,351




9


136,873,835


95.80


6,001,726


4.20


524,314


142,875,561



* Includes discretionary votes
 
Those members in attendance voted unanimously in favour of the resolutions.
 
For further information, please contact:
 



Kromek Group plc








Arnab Basu, CEO
Derek Bulmer, CFO
 


+44 (0)1740 626 060




Cenkos Securities plc (Nominated Adviser)








Max Hartley (NOMAD)
Julian Morse (Sales)
 


+44 (0)20 7397 8900




Luther Pendragon Ltd (PR)








Harry Chathli
Claire Norbury
Alexis Gore
Joe Quinlan


+44 (0)20 7618 9100



 
 




 
About Kromek Group plc
 
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
 
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
 
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
 
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
 
Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEAANKAFANEFF